Principal Financial Group Inc. Reduces Stock Position in Envista Holdings Co. (NYSE:NVST)

Principal Financial Group Inc. reduced its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 1.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 394,540 shares of the company’s stock after selling 3,906 shares during the quarter. Principal Financial Group Inc. owned 0.23% of Envista worth $7,611,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in NVST. GAMMA Investing LLC raised its holdings in Envista by 30.5% in the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company’s stock valued at $44,000 after acquiring an additional 538 shares in the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after purchasing an additional 728 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares during the last quarter. Huntington National Bank lifted its position in shares of Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after purchasing an additional 949 shares during the last quarter. Finally, State of Alaska Department of Revenue grew its stake in Envista by 7.3% in the third quarter. State of Alaska Department of Revenue now owns 19,887 shares of the company’s stock worth $392,000 after purchasing an additional 1,355 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a report on Tuesday, February 25th. Morgan Stanley raised their price objective on Envista from $19.00 to $20.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 6th. Jefferies Financial Group boosted their target price on shares of Envista from $20.00 to $22.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Mizuho initiated coverage on shares of Envista in a research report on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 price target on the stock. Finally, Wells Fargo & Company boosted their price objective on shares of Envista from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Thursday, February 6th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Envista currently has an average rating of “Hold” and a consensus target price of $20.21.

Envista Stock Performance

NVST opened at $19.93 on Friday. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. The business’s 50 day moving average is $20.29 and its 200-day moving average is $19.67. The stock has a market cap of $3.43 billion, a PE ratio of -3.07, a price-to-earnings-growth ratio of 1.27 and a beta of 1.34. Envista Holdings Co. has a twelve month low of $15.15 and a twelve month high of $23.00.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, analysts predict that Envista Holdings Co. will post 1 earnings per share for the current year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.